Melinta Therapeutics Announces Multiple Presentations at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

NEXT STORY
Oncology Venture invites to a webcast April 8 at 16:30
PREV STORY
Evolus Announces Publication of Largest Aesthetic Head-to-Head Pivotal Trial Comparing Jeuveau™ and BOTOX® in Aesthetic Surgery Journal
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Matinas BioPharma Reports Second Quarter 2021 Financial Results and Operational Highlights

author_avatar
NASDAQ Market News

Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

author_avatar
NASDAQ Market News

Nanobiotix announces submission for first market approval of lead product NBTXR3 in Europe

      CE Mark filing based on current level of scientific and clinical evidence Phase II/III ...

author_avatar
NASDAQ Market News